Skip to main content
. 2014 Jul 15;48(16):9600–9608. doi: 10.1021/es501811k

Table 3. Geometric Mean Maternal Prenatal (16 weeks) Concentrations of PFOS, PFOA, PFNA, PFHxS, and Me-PFOSA-AcOH (μg/L) According to Demographic, Perinatal and Lifestyle Factorsa.

variables   PFOS
PFOA
PFNA
PFHxS
Me-PFOSA-AcOH
N (%) GM (95% CI) GM ratio (95% CI) GM (95% CI) GM ratio (95% CI) GM (95% CI) GM ratio (95% CI) GM (95% CI) GM ratio (95% CI) GM (95% CI) GM ratio (95% CI)
maternal age (years)
<25 40 (22) 10.87 (9.16–12.9) 0.8 (0.65–0.97)b 4.89 (4.12–5.81) 0.94 (0.77–1.14) 0.73 (0.64–0.83) 0.91 (0.78–1.05) 1.02 (0.8–1.29) 0.63 (0.48–0.83)b 0.47 (0.38–0.57) 1.12 (0.88–1.41)
>35 30 (16) 14.94 (12.26–18.21) 1.09 (0.87–1.37) 6.77 (5.55–8.26) 1.3 (1.04–1.62)b 0.93 (0.8–1.07) 1.15 (0.98–1.36) 1.65 (1.26–2.16) 1.02(0.75–1.38) 0.43 (0.34–0.54) 1.02 (0.78–1.32)
25–34 112 (62) 13.67 (12.34–15.14) ref 5.22 (4.71–5.79) ref 0.8 (0.75–0.87) ref 1.62 (1.41–1.87) ref 0.42 (0.37–0.47) ref
race
non-hispanic black 56 (31.1) 10.85 (9.4–12.53) 0.76 (0.64–0.9)b 4.41 (3.82–5.1) 0.75 (0.63–0.9)b 0.73 (0.65–0.81) 0.86 (0.76–0.98)b 0.86 (0.72–1.03) 0.47 (0.38–0.59)b 0.46 (0.39–0.54) 1.12 (0.91–1.38)
other 10 (5.6) 16.07 (11.43–22.59) 1.12 (0.79–1.6) 6.05 (4.3–8.53) 1.03 (0.72–1.47) 0.98 (0.76–1.26) 1.17 (0.9–1.52) 2.43 (1.58–3.74) 1.34(0.85–2.09) 0.51 (0.34–0.76) 1.25 (0.83–1.89)
non-hispanic white 114 (63.3) 14.3 (12.93–15.82) ref 5.87 (5.3–6.5) ref 0.84 (0.78–0.9) ref 1.82 (1.6–2.07) ref 0.41 (0.36–0.46) ref
household income
<$20 000 29 (16) 9.44 (7.73–11.51) 0.63 (0.49–0.81)b 4.1 (3.35–5.03) 0.7 (0.54–0.9)b 0.64 (0.55–0.74) 0.77 (0.64–0.93)b 0.84 (0.64–1.1) 0.49 (0.35–0.69)b 0.48 (0.38–0.6) 1.02 (0.76–1.36)
$20 000–$40 000 37 (20.6) 13.29 (11.15–15.85) 0.89 (0.71–1.13) 5.35 (4.47–6.4) 0.91 (0.72–1.15) 0.84 (0.74–0.96) 1.02 (0.86–1.21) 1.4 (1.1–1.77) 0.82 (0.59–1.12) 0.43 (0.35–0.53) 0.92 (0.7–1.21)
$40 000–$80 000 64 (35.6) 13.98 (12.23–15.98) 0.94 (0.77–1.15) 5.69 (4.96–6.52) 0.97 (0.79–1.19) 0.86 (0.78–0.95) 1.04 (0.9–1.21) 1.72 (1.43–2.06) 1 (0.76–1.32) 0.38 (0.33–0.45) 0.81 (0.64–1.03)
>$80 000 50 (27.8) 14.87 (12.78–17.3) ref 5.89 (5.05–6.87) ref 0.83 (0.74–0.92) ref 1.71 (1.39–2.1) ref 0.47 (0.39–0.56) ref
BMIc
obese (≥30 kg/m2) 67 (36.8) 11.45 (9.77–13.43) 0.81 (0.66–1)b 4.95 (4.22–5.82) 0.88 (0.71–1.08) 0.7 (0.63–0.79) 0.81 (0.7–0.94)b 1.22 (0.98–1.52) 0.84 (0.63–1.11) 0.44 (0.36–0.52) 0.93 (0.73–1.17)
overweight (25– 29.9 kg/m2) 47 (25.8) 13.59 (11.89–15.54) 0.97 (0.8–1.17) 5.45 (4.75–6.24) 0.96 (0.8–1.17) 0.84 (0.76–0.92) 0.96 (0.84–1.1) 1.71 (1.42–2.06) 1.17 (0.9–1.52) 0.39 (0.34–0.46) 0.83 (0.67–1.04)
normal (<24.9 kg/m2) 66 (36.4) 14.08 (12.32–16.08) ref 5.65 (4.93–6.46) ref 0.87 (0.79–0.96) ref 1.46 (1.21–1.76) ref 0.47 (0.4–0.55) ref
breast feeding history
prev breast feed 74 (41) 11.85 (10.44–13.45) 0.83 (0.71–0.98)b 4.47 (3.95–5.06) 0.73 (0.62–.86)b 0.77 (0.7–0.85) 0.93(0.82–1.05) 1.34 (1.13–1.61) 0.86 (0.69–1.09) 0.43 (0.37–0.5) 0.99 (0.82–1.2)
not prev breast feed 108 (59) 14.2 (12.78–15.76) ref 6.1 (5.5–6.75) ref 0.83 (0.77–0.9) ref 1.56 (1.35–1.8) ref 0.43 (0.38–0.49) ref
education
<12 years 12 (6.7) 11.08 (8.07–15.23) 0.81 (0.58–1.13) 4.99 (3.62–6.88) 0.92 (0.66–1.28) 0.69 (0.55–0.87) 0.84 (0.66–1.07) 0.94 (0.61–1.45) 0.59 (0.38–0.93)b 0.51 (0.36–0.73) 1.24 (0.85–1.8)
12 years 25 (13.9) 11.77 (9.45–14.67) 0.86 (0.68–1.09) 5.24 (4.19–6.54) 0.96 (0.76–1.23) 0.8 (0.68–0.94) 0.97 (0.82–1.16) 1.14 (0.84–1.54) 0.72 (0.52–1.00)b 0.5 (0.39–0.64) 1.2 (0.91–1.58)
>12 years 143 (79.4) 13.68 (12.48–15) ref 5.44 (4.96–5.97) ref 0.82 (0.77–0.88) ref 1.59 (1.4–1.8) ref 0.41 (0.37–0.46) ref
gestational age
preterm (<37 weeks) 14 (7.7) 11.25 (8.39–15.09) 0.84 (0.62–1.14) 5.18 (3.85–6.96) 0.96 (0.71–1.31) 0.73 (0.59–0.91) 0.9 (0.72–1.13) 1.31 (0.87–1.97) 0.89 (0.58–1.36) 0.5 (0.36–0.7) 1.18 (0.83–1.68)
term (≥37 weeks) 168 (92.3) 13.37 (12.28–14.55) ref 5.39 (4.95–5.87) ref 0.81 (0.76–0.86) ref 1.48 (1.32–1.67) ref 0.43 (0.39–0.47) ref
serum cotinine (μg/L)
active smoker (≥3) 14 (7.7) 9.04 (6.76–12.07) 0.68 (0.49–0.94)b 4.76 (3.55–6.39) 0.95 (0.68–1.32) 0.66 (0.53–0.81) 0.82 (0.64–1.04) 1.06 (0.7–1.59) 0.67 (0.42–1.06) 0.43 (0.31–0.61) 1.12 (0.76–1.63)
secondhand smoker (0.015–3) 117 (64.3) 13.76 (12.45–15.21) 1.04 (0.86–1.24) 5.61 (5.07–6.22) 1.12 (0.93–1.34) 0.83 (0.77–0.89) 1.03 (0.9–1.18) 1.48 (1.29–1.7) 0.94 (0.73–1.22) 0.45 (0.4–0.51) 1.16 (0.94–1.43)
non smoker (<0.015) 51 (28) 13.28 (11.41–15.45) ref 5.03 (4.31–5.87) ref 0.8 (0.72–0.9) ref 1.57 (1.27–1.95) ref 0.39 (0.33–0.46) ref
parity
>1 47 (25.8) 11.37 (9.7–13.33) 0.78 (0.64–0.96)b 4.83 (4.14–5.64) 0.74 (0.61–0.91)b 0.75 (0.67–0.85) 0.87 (0.75–1.01) 1.31 (1.05–1.64) 0.79 (0.6–1.05) 0.52 (0.43–0.62) 1.08 (0.85–1.36)
1 57 (31.3) 13.06 (11.31–15.08) 0.9 (0.74–1.09) 4.53 (3.94–5.21) 0.7 (0.58–0.84)b 0.77 (0.7–0.86) 0.89 (0.78–1.03) 1.36 (1.11–1.67) 0.82 (0.63–1.07) 0.5 (0.42–0.59) 1.04 (0.84–1.3)
0 78 (42.9) 14.53 (12.85–16.43) ref 6.49 (5.76–7.32) ref 0.86 (0.79–0.95) ref 1.65 (1.39–1.97) ref 0.48 (0.42–0.55) ref
a

Ratios are the exponentiated beta coefficients from a linear regression model with the maternal concentrations as the outcome. Ratios represent the multiplicative difference in PFAS concentrations from the reference category. Thus, numeric estimates indicate that GM concentrations were higher (>1) or lower (<1) for the predictor (variable) in that category compared with the reference category. Each predictor was run in a separate model.

b

P < 0.05.

c

We excluded two underweight participants with BMI <18 kg/m2.